Novo CEO Doustdar to Pfizer on Metsera Takeover Battle: ‘Bid Higher’
Novo Nordisk again increased its offer for Metsera as its takeover battle with Pfizer for the obesity startup escalates. CEO…
Tag: Doustdar
Novo Nordisk CEO Doustdar on Headwinds, Metsera Bid, US Pricing
Novo Nordisk CEO Maziar Mike Doustdar discusses demand for the Danish firm’s weight-loss drug Wegovy and diabetes medication Ozempic. He…